Patient Involvement Blog

Latest Tweets

News Archives

News Category: Cancer

Public Health Minister Visits Oxford Cancer Hospital ahead of World Cancer Day

Ahead of World Cancer Day on February 4, Public Health Minister Nicola Blackwood highlighted the importance of UK scientific research to beating cancer during a visit to the Churchill Hospital. The Public Health and Innovation Minister saw state-of-the-art clinical trials and facilities for new cancer treatments and patients, both supported by the NIHR Oxford Biomedical … Read more

Monitoring prostate cancer “as effective as surgery”

Active monitoring of prostate cancer is as effective as surgery and radiotherapy, in terms of survival at 10 years, reports the largest study of its kind, funded by the National Institute for Health Research (NIHR). Results published in New England Journal of Medicine today, show that all three treatments result in similar, and very low, … Read more

Discoveries offer hope for managing ovarian cancer

Oxford University researchers have found a way to detect ovarian cancer early and identified an enzyme that is key in making ovarian cancer more deadly. Their results, published in two journals and co-funded by the NIHR Oxford Biomedical Research Centre, provide new research routes for scientists trying to detect and beat the disease. Ovarian cancer … Read more

Rare mutations in bowel cancer may identify patients with a better prognosis

An international collaboration between the University of Oxford and other European institutions has uncovered a correlation between a rare mutation in bowel cancers and a better prognosis, raising the possibility that patients with such tumours may not require chemotherapy after surgery. The study focused on colorectal (bowel) cancers and examined the presence of mutations in … Read more

Data debate video and podcast now online

A video of an hour-long debate on issues around mass sharing of patient data to support research and improve patient care can now be viewed online. “Good to share? Data, research, privacy and the NHS” was held as part of the NIHR Oxford Biomedical Research Centre’s Public Open Day – Celebrating Biomedical Research on April … Read more

Prostate cancer vaccine trial seeks volunteers

Oxford University scientists have started a clinical trial to test a new vaccine against prostate cancer and are looking for volunteers to take part. The first four participants have already received this experimental vaccine at the Churchill Hospital in Oxford, and the second trial site has just been opened at the Royal Hallamshire Hospital in … Read more

New clinical trial to tackle hard-to-treat leukaemia

A new clinical trial at Oxford’s Churchill Hospital plans to study the safety of a new experimental drug to treat a form of leukaemia, called Acute Myeloid Leukaemia (AML). Acute myeloid leukaemia is the most common aggressive blood cancer and there are about 2,200 new cases in the UK each year. It can be hard … Read more

Precision medicine boost for Oxford

Oxford is today named as a centre for excellence leading the drive to tailor more treatments to the needs of individual patients. A Precision Medicine Catapult centre will be established in Oxford bringing together business and research to develop new products and services. This project will be led by the Oxford Academic Health Science Network … Read more

BRC supports herpes virus cancer trial

THE NIHR Oxford Biomedical Research Centre has supported research that found a genetically engineered herpes virus can halt the progression of skin cancer. Patients from Oxford’s Churchill Hospital took part in the landmark clinical trial, which comprised 64 worldwide centres. It found the virus can kill cancer cells and spark the immune system into action … Read more

Gene sequencing test for cancer patients on the NHS

The first multi-gene DNA sequencing test that can help predict cancer patients’ responses to treatment has been launched in the National Health Service (NHS), thanks to a partnership between scientists at the University of Oxford and Oxford University Hospitals NHS Trust. The test uses the latest DNA sequencing techniques to detect mutations across 46 genes … Read more

Royal visit to Oxford’s Churchill Hospital

The Duke of York visited the Churchill Hospital in Oxford today to mark the opening of the new building. The building, that includes an integrated Cancer and Haematology Centre, provides a base for many NIHR Oxford Biomedical Research Centre projects. Chairman of Oxford University Hospitals NHS Trust, Dame Fiona Caldicott said: “We were absolutely delighted … Read more

Trial to investigate new drug combination in lung cancer

Cancer Research UK’s Drug Development Office has opened the first trial of a new drug combination in patients with advanced solid tumours and in a subset of patients who have non-small cell lung cancer. This trial will combine two compounds that aim to starve the tumours while simultaneously blocking cancer cell growth. The study will … Read more

Can daily aspirin help prevent and treat cancer?

A collection of three papers (two published in The Lancet and one in The Lancet Oncology) add to the growing evidence base suggesting that daily aspirin can be used to help prevent and possibly treat cancer.  All three papers are by Professor Peter Rothwell, University of Oxford and John Radcliffe Hospital, and colleagues. The case for using aspirin to prevent cancer continues to build, … Read more

Research@Oxford – Improving Health

On 14th March 2012 the NIHR Biomedical Research Centre and the Oxford Cancer Research Centre (right) hosted a public open day on research that is designed to improve health.  A morning session was held for secondary schools, introducing them to the world of cancer research.  Scientists, doctors, nurses and technicians were on hand to demonstrate the latest … Read more

New treatment for lung, liver and renal tumours

Doctors, surgeons and researchers from the Imaging Theme of the NIHR Biomedical Research Centre, Oxford are looking into the effectiveness of using ablation as another treatment option for lung, liver and renal tumours. Microwave Ablation is used to treat small tumors by passing a needle-like probe inside the tumour. The microwaves released from the probe increase the temperature within tumour tissue that … Read more

Ten years of collaboration brings new hope for patients

NIHR funded doctors, surgeons and scientists from the HIFU Unit (high intensity focused ultrasound), marked its official opening at the Churchill Hospital after a 10 year collaboration with the Haifu Company of China. The £1.5m Oxford HIFU machine has been given on long-term loan from the Haifu Company and was recently used to treat 72 year old David Atwell, … Read more

Researchers trial new drug for women with hereditary breast and ovarian cancer

A CANCER RESEARCH UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford. The trial, led by a team based at the National Institute for Health Research (NIHR) Oxford Biomedical Research … Read more

Small molecules found to play complex role in cancer metastasis

While they may be small in size, a family of tiny molecules called microRNAs could potentially play a large role in the process of cancer metastasis, or the spread of cancer from one area of the body to another. A team of researchers from The Cancer Institute of New Jersey (CINJ) and Princeton University, along … Read more

HIFU in the news

High Intensity Focused Ultrasound (HIFU) was featured in a new flagship programme for BBC World news called The Health Show. Dr David Cranston and the inventor of HIFU in China, Professor Wu talked about the benefits to patients of using HIFU compared to that of more invasive surgery.  The technique is being used at the Churchill Hospital in … Read more

Oxford blood cancer patients to benefit from new clinical trials network

The Churchill Hospital in Oxford has been named as a centre in a unique new clinical trial network with access to millions of pounds worth of life-saving drugs for blood cancer patients. Oxford will be one of just thirteen centres in the national network, set up by the charity Leukaemia & Lymphoma Research in response … Read more